Download PDF
Frauenheilkunde up2date 2024; 18(01): 29-44
DOI: 10.1055/a-1631-3635
Gynäkologische Onkologie

Stellenwert der Sentinel-Lymphonodektomie beim Vulva- und Zervixkarzinom

Lisa Jung
,
Nina Albers
,
Julia Waldschmidt 
,
Ingolf Juhasz-Böss
,
Markus Medl
› Further Information
Also available at
    Permissions and Reprints All articles of this category

Die Beurteilung der lymphatischen Metastasierung ist ein essenzieller Bestandteil des Stagings solider Tumoren. Mit der Sentinel-Lymphknoten-(SLN-)Biopsie steht ein minimalinvasives Verfahren zur Verfügung, dessen diagnostischer Stellenwert bei den Genitalkarzinomen unterschiedlich bewertet wird. Diese Übersichtsarbeit gründet sich auf einer leitlinienbasierten Literaturrecherche und berücksichtigt aktuelle Studien und Kongressbeiträge.
Kernaussagen

  • Die Beurteilung der lymphatischen Metastasierung ist ein essenzieller Bestandteil des Stagings solider Tumoren.

  • Jede 5. Frau mit Vulvakarzinom bzw. jede 4. mit Zervixkarzinom weist zum Zeitpunkt der Diagnosestellung bereits eine lymphatische Metastasierung auf [4].

  • Mit der Sentinel-Lymphknoten-(SLN-)Biopsie steht ein minimalinvasives Verfahren zur Verfügung, das eine Einschätzung über den regionären Tumorbefall von Lymphknoten erlaubt und die Morbidität einer systematischen Lymphonodektomie verringert.

  • Es weist zudem sozioökonomische Vorteile auf.

  • Das SLN-Verfahren ist heute bereits beim Mammakarzinom und Malignen Melanom standardisiert und etabliert.

  • Für selektierte Patientinnen mit Vulvakarzinom im Frühstadium gilt die SLN-Technik in Leitlinien als etabliert vor.

  • Beim Zervixkarzinom zeigt sich das SLN-Verfahren bei Primärtumoren < 2 cm als günstig; es ist jedoch noch nicht ausreichend standardisiert. Weitere Studien laufen derzeit dazu.

  • Die präoperative Lymphoszintigrafie stellt ein entscheidendes diagnostisches Instrumentarium dar, um SLN auch bei abweichenden anatomischen Verhältnissen zu detektieren und die Rate falsch negativer Befunde zu reduzieren [52].

  • Künftige Leitlinien und aktuelle Studien werden genauer definieren müssen, welche Patientengruppen von der SLN-Technik in Diagnostik und Therapie profitieren können.

Schlüsselwörter

Zervixkarzinom - Vulvakarzinom - Sentinel-Lymphknoten - Ultrastaging - Mikrometastasen


Publication History

Article published online:
13 February 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Morton DL, Wen DR, Wong JH. et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392-399
    CrossrefPubMedSearch in Google Scholar
  • 2 Cody HS. Sentinel lymph node mapping in breast cancer. Breast Cancer 1999; 6: 13-22
    CrossrefPubMedSearch in Google Scholar
  • 3 Mocellin S, Hoon DSB, Pilati P. et al. Sentinel lymph node molecular ultrastaging in patients with melanoma: a systematic review and meta-analysis of prognosis. J Clin Oncol 2007; 25: 1588-1595
    CrossrefPubMedSearch in Google Scholar
  • 4 AWMF. Diagnostik, Therapie und Nachsorge des Vulvakarzinoms und seiner Vorstufen. Register-Nummer 015–059.
  • 5 AWMF. S3-Leitlinie Diagnostik, Therapie und Nachsorge der Patientin mit Zervixkarzinom. Accessed November 14, 2023 at: https://www.awmf.org/leitlinien/detail/ll/032–033OL.html
  • 6 AWMF. S3-Leitlinie Endometriumkarzinom. Accessed November 14, 2023 at: https://www.awmf.org/leitlinien/detail/ll/032–034OL.html
  • 7 Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin 2017; 67: 7-30
    CrossrefPubMedSearch in Google Scholar
  • 8 Taran FA, Jung L, Waldschmidt J. et al. Status of Sentinel Lymph Node Biopsy in Endometrial Cancer. Geburtshilfe Frauenheilkd 2021; 81: 562-573
    Thieme ConnectPubMedSearch in Google Scholar
  • 9 Zentrum der Krebsregisterdaten. Vulva: Übersicht über die wichtigsten epidemiologischen Maßzahlen für Deutschland, ICD-10 C51. Berlin: Robert Koch-Institut; 2016. Accessed November 14, 2023 at: https://www.krebsdaten.de/Krebs/DE/Content/Publikationen/Krebs_in_Deutschland/kid_2019/kid_2019_c51_vulva.pdf?__blob=publicationFile
    Search in Google Scholar
  • 10 Mahner S, Jueckstock J, Hilpert F. et al. Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 study. J Natl Cancer Inst 2015; 107: dju426
    CrossrefPubMedSearch in Google Scholar
  • 11 Levenback C, Burke TW, Gershenson DM. et al. Intraoperative lymphatic mapping for vulvar cancer. Obstet Gynecol 1994; 84: 163-167
    CrossrefPubMedSearch in Google Scholar
  • 12 Van der Zee AGJ, Oonk MH, De Hullu JA. et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol 2008; 26: 884-889
    CrossrefPubMedSearch in Google Scholar
  • 13 Oncology (ESGO) TES of G. ESGO 2017 Congress, November 4–7, 2017 in Vienna, Austria. ESGO Gynae-Oncology Guidelines. Accessed November 14, 2023 at: https://guidelines.esgo.org/vulvar-cancer/panel/working-groups/
  • 14 Hassanzade M, Attaran M, Treglia G. et al. Lymphatic mapping and sentinel node biopsy in squamous cell carcinoma of the vulva: systematic review and meta-analysis of the literature. Gynecol Oncol 2013; 130: 237-245
    CrossrefPubMedSearch in Google Scholar
  • 15 Oonk MH, van Hemel BM, Hollema H. et al. Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study. Lancet Oncol 2010; 11: 646-652
    CrossrefPubMedSearch in Google Scholar
  • 16 Vidal-Sicart S, Puig-Tintoré LM, Lejárcegui JA. et al. Validation and application of the sentinel lymph node concept in malignant vulvar tumours. Eur J Nucl Med Mol Imaging 2007; 34: 384-391
    CrossrefPubMedSearch in Google Scholar
  • 17 Hampl M, Hantschmann P, Michels W. et al. Validation of the accuracy of the sentinel lymph node procedure in patients with vulvar cancer: results of a multicenter study in Germany. Gynecol Oncol 2008; 111: 282-288
    CrossrefPubMedSearch in Google Scholar
  • 18 Achimas-Cadariu P, Harter P, Fisseler-Eckhoff A. et al. Assessment of the sentinel lymph node in patients with invasive squamous carcinoma of the vulva. Acta Obstet Gynecol Scand 2009; 88: 1209-1214
    CrossrefPubMedSearch in Google Scholar
  • 19 Devaja O, Mehra G, Coutts M. et al. A prospective study of sentinel lymph node detection in vulval carcinoma: is it time for a change in clinical practice?. Int J Gynecol Cancer 2011; 21: 559-564
    CrossrefPubMedSearch in Google Scholar
  • 20 Levenback CF, Ali S, Coleman RL. et al. Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study. J Clin Oncol 2012; 30: 3786-3791
    CrossrefPubMedSearch in Google Scholar
  • 21 Euscher ED, Malpica A. Gynaecological malignancies and sentinel lymph node mapping: an update. Histopathology 2020; 76: 139-150
    CrossrefPubMedSearch in Google Scholar
  • 22 Covens A, Vella ET, Kennedy EB. et al. Sentinel lymph node biopsy in vulvar cancer: Systematic review, meta-analysis and guideline recommendations. Gynecol Oncol 2015; 137: 351-361
    CrossrefPubMedSearch in Google Scholar
  • 23 Moore RG, Granai CO, Gajewski W. et al. Pathologic evaluation of inguinal sentinel lymph nodes in vulvar cancer patients: a comparison of immunohistochemical staining versus ultrastaging with hematoxylin and eosin staining. Gynecol Oncol 2003; 91: 378-382
    CrossrefPubMedSearch in Google Scholar
  • 24 Meads C, Sutton AJ, Rosenthal AN. et al. Sentinel lymph node biopsy in vulval cancer: systematic review and meta-analysis. Br J Cancer 2014; 110: 2837-2846
    CrossrefPubMedSearch in Google Scholar
  • 25 Reade CJ, Jimenez W, O’Reilly D. et al. Sentinel lymph node biopsy in vulvar cancer: a health technology assessment for the canadian health care context. J Obstet Gynaecol Can 2012; 34: 1053-1065
    CrossrefPubMedSearch in Google Scholar
  • 26 Oonk MHM, van Os MA, de Bock GH. et al. A comparison of quality of life between vulvar cancer patients after sentinel lymph node procedure only and inguinofemoral lymphadenectomy. Gynecol Oncol 2009; 113: 301-305
    CrossrefPubMedSearch in Google Scholar
  • 27 Brammen L, Staudenherz A, Polterauer S. et al. Sentinel lymph node detection in vulvar cancer patients: a 20 years analysis. Hell J Nucl Med 2014; 17: 184-189
    CrossrefPubMedSearch in Google Scholar
  • 28 Hefler LA, Grimm C, Six L. et al. Inguinal sentinel lymph node dissection vs. complete inguinal lymph node dissection in patients with vulvar cancer. Anticancer Res 2008; 28: 515-517
    PubMedSearch in Google Scholar
  • 29 Coleman RL, Ali S, Levenback CF. et al. Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always necessary? An analysis from Gynecologic Oncology Group (GOG) 173. Gynecol Oncol 2013; 128: 155-159
    CrossrefPubMedSearch in Google Scholar
  • 30 Te Grootenhuis NC, van der Zee AGJ, van Doorn HC. et al. Sentinel nodes in vulvar cancer: Long-term follow-up of the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I. Gynecol Oncol 2016; 140: 8-14
    CrossrefPubMedSearch in Google Scholar
  • 31 Oonk M, Slomovitz B, Baldwin P. et al. Radiotherapy instead of inguinofemoral lymphadenectomy in vulvar cancer patients with a metastatic sentinel node: results of GROINSS-V II. In: Best Oral/Late-Breaking Abstracts 4 – Miscellaneous. BMJ Publishing Group Ltd; 2019: A14.1-A14 Accessed November 14, 2023 at: http://ijgc.bmj.com/lookup/doi/10.1136/ijgc-2019-ESGO.16
    Search in Google Scholar
  • 32 Lindell G, Jonsson C, Ehrsson RJ. et al. Evaluation of preoperative lymphoscintigraphy and sentinel node procedure in vulvar cancer. Eur J Obstet Gynecol Reprod Biol 2010; 152: 91-95
    CrossrefPubMedSearch in Google Scholar
  • 33 Louis-Sylvestre C, Evangelista E, Leonard F. et al. Sentinel node localization should be interpreted with caution in midline vulvar cancer. Gynecol Oncol 2005; 97: 151-154
    CrossrefPubMedSearch in Google Scholar
  • 34 Woelber L, Eulenburg C, Grimm D. et al. The risk of contralateral non-sentinel metastasis in patients with primary vulvar cancer and unilaterally positive sentinel node. Ann Surg Oncol 2016; 23: 2508-2514
    CrossrefPubMedSearch in Google Scholar
  • 35 Robert Koch-Institut. Zentrum für Krebsregisterdaten. Gebärmutterhalskrebs (Zervixkarzinom). Accessed November 14, 2023 at: https://www.krebsdaten.de/Krebs/DE/Content/Krebsarten/Gebaermutterhalskrebs/gebaermutterhalskrebs_node.html
  • 36 RKI. Accessed December 18, 2023 at: https://www.krebsdaten.de/Krebs/DE/Content/Krebsarten/Gebaermutterhalskrebs/gebaermutterhalskrebs.html
  • 37 Euscher ED, Malpica A, Atkinson EN. et al. Ultrastaging improves detection of metastases in sentinel lymph nodes of uterine cervix squamous cell carcinoma. Am J Surg Pathol 2008; 32: 1336-1343
    CrossrefPubMedSearch in Google Scholar
  • 38 Koh W-J, Abu-Rustum NR, Bean S. et al. Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2019; 17: 64-84
    CrossrefPubMedSearch in Google Scholar
  • 39 Oncology (ESGO) TES of G. ESGO 2017 congress, November 4–7, 2017 in Vienna, Austria. ESGO Gynae-Oncology Guidelines. Accessed November 14, 2023 at: https://guidelines.esgo.org/cervical-cancer/guidelines/recommendations/
  • 40 Darin MC, Gómez-Hidalgo NR, Westin SN. et al. Role of indocyanine green in sentinel node mapping in gynecologic cancer: Is fluorescence imaging the new standard?. J Minim Invasive Gynecol 2016; 23: 186-193
    CrossrefPubMedSearch in Google Scholar
  • 41 Roy M, Bouchard-Fortier G, Popa I. et al. Value of sentinel node mapping in cancer of the cervix. Gynecol Oncol 2011; 122: 269-274
    CrossrefPubMedSearch in Google Scholar
  • 42 Bats A-S, Buénerd A, Querleu D. et al. Diagnostic value of intraoperative examination of sentinel lymph node in early cervical cancer: a prospective, multicenter study. Gynecol Oncol 2011; 123: 230-235
    CrossrefPubMedSearch in Google Scholar
  • 43 Balaya V, Guani B, Benoit L. et al. Diagnostic value of frozen section examination of sentinel lymph nodes in early-stage cervical cancer at the time of ultrastaging. Gynecol Oncol 2020; 158: 576-583
    CrossrefPubMedSearch in Google Scholar
  • 44 Lécuru F, Mathevet P, Querleu D. et al. Bilateral negative sentinel nodes accurately predict absence of lymph node metastasis in early cervical cancer: results of the SENTICOL study. J Clin Oncol 2011; 29: 1686-1691
    CrossrefPubMedSearch in Google Scholar
  • 45 Cibula D, Abu-Rustum NR, Dusek L. et al. Prognostic significance of low volume sentinel lymph node disease in early-stage cervical cancer. Gynecol Oncol 2012; 124: 496-501
    CrossrefPubMedSearch in Google Scholar
  • 46 Salvo G, Ramirez PT, Levenback CF. et al. Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer. Gynecol Oncol 2017; 145: 96-101
    CrossrefPubMedSearch in Google Scholar
  • 47 Mathevet P, Guani B, Ciobanu A. et al. Histopathologic validation of the sentinel node technique in early-stage cervical cancer patients. JCO 2020; 38: 6028-6028
    CrossrefPubMedSearch in Google Scholar
  • 48 Selman TJ, Mann C, Zamora J. et al. Diagnostic accuracy of tests for lymph node status in primary cervical cancer: a systematic review and meta-analysis. CMAJ 2008; 178: 855-862
    CrossrefPubMedSearch in Google Scholar
  • 49 Niikura H, Tsuji K, Tokunaga H. et al. Sentinel node navigation surgery in cervical and endometrial cancer: a review. Jpn J Clin Oncol 2019; 49: 495-500
    CrossrefPubMedSearch in Google Scholar
  • 50 Gianoni M, Mathevet P, Uzan C. et al. Does the sentinel lymph node sampling alone improve quality of life in early cervical cancer management?. Front Surg 2020; 7: 31
    CrossrefPubMedSearch in Google Scholar
  • 51 Bats A-S, Mathevet P, Buenerd A. et al. The sentinel node technique detects unexpected drainage pathways and allows nodal ultrastaging in early cervical cancer: insights from the multicenter prospective SENTICOL study. Ann Surg Oncol 2013; 20: 413-422
    CrossrefPubMedSearch in Google Scholar
  • 52 Bats A-S, Frati A, Mathevet P. et al. Contribution of lymphoscintigraphy to intraoperative sentinel lymph node detection in early cervical cancer: Analysis of the prospective multicenter SENTICOL cohort. Gynecol Oncol 2015; 137: 264-269
    CrossrefPubMedSearch in Google Scholar
  • 53 Marnitz S, Köhler C, Bongardt S. et al. Topographic distribution of sentinel lymph nodes in patients with cervical cancer. Gynecol Oncol 2006; 103: 35-44
    CrossrefPubMedSearch in Google Scholar
  • 54 Cibula D, Abu-Rustum NR, Dusek L. et al. Bilateral ultrastaging of sentinel lymph node in cervical cancer: Lowering the false-negative rate and improving the detection of micrometastasis. Gynecol Oncol 2012; 127: 462-466
    CrossrefPubMedSearch in Google Scholar
  • 55 Altgassen C, Hertel H, Brandstädt A. et al. Multicenter validation study of the sentinel lymph node concept in cervical cancer: AGO Study Group. J Clin Oncol 2008; 26: 2943-2951
    CrossrefPubMedSearch in Google Scholar
  • 56 Balaya V, Bresset A, Guani B. et al. Risk factors for failure of bilateral sentinel lymph node mapping in early-stage cervical cancer. Gynecol Oncol 2020; 156: 93-99
    CrossrefPubMedSearch in Google Scholar
  • 57 Cibula D, McCluggage WG. Sentinel lymph node (SLN) concept in cervical cancer: Current limitations and unanswered questions. Gynecol Oncol 2019; 152: 202-207
    CrossrefPubMedSearch in Google Scholar
  • 58 Popa I, Plante M, Renaud M-C. et al. Negative sentinel lymph node accurately predicts negative status of pelvic lymph nodes in uterine cervix carcinoma. Gynecol Oncol 2006; 103: 649-653
    CrossrefPubMedSearch in Google Scholar
  • 59 Barranger E, Cortez A, Commo F. et al. Histopathological validation of the sentinel node concept in cervical cancer. Ann Oncol 2004; 15: 870-874
    CrossrefPubMedSearch in Google Scholar
  • 60 Okamoto S, Niikura H, Yoshinaga K. et al. Detection of micrometastases in cervical cancer with a system that evaluates both sentinel and nonsentinel lymph nodes. Int J Gynecol Cancer 2009; 19: 708-711
    CrossrefPubMedSearch in Google Scholar
  • 61 Cibula D, Zikan M, Slama J. et al. Risk of micrometastases in non-sentinel pelvic lymph nodes in cervical cancer. Gynecol Oncol 2016; 143: 83-86
    CrossrefPubMedSearch in Google Scholar
  • 62 Colturato LF, Signorini Filho RC, Fernandes RCM. et al. Lymph node micrometastases in initial stage cervical cancer and tumoral recurrence. Int J Gynaecol Obstet 2016; 133: 69-75
    CrossrefPubMedSearch in Google Scholar
  • 63 Guani B, Dorez M, Magaud L. et al. Impact of micrometastasis or isolated tumor cells on recurrence and survival in patients with early cervical cancer: SENTICOL Trial. Int J Gynecol Cancer 2019; 29: 447-452
    CrossrefPubMedSearch in Google Scholar
  • 64 Guani B, Balaya V, Magaud L. et al. The Clinical Impact of Low-Volume Lymph Nodal Metastases in Early-Stage Cervical Cancer: The Senticol 1 and Senticol 2 Trials. Cancers (Basel) 2020; 12: 1061
    CrossrefPubMedSearch in Google Scholar
  • 65 Balaya V, Guani B, Magaud L. et al. Long-term oncological safety of sentinel lymph node biopsy in early-stage cervical cancer. JCO 2020; 38: 6006-6006
    CrossrefPubMedSearch in Google Scholar